Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-20T01:01:16.171Z Has data issue: false hasContentIssue false

Chapter 7 - Chagas Disease

from Section 1 - Infectious Conditions

Published online by Cambridge University Press:  15 June 2018

By
Ayrton R. Massaro
Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 44 - 51
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Antunes, AF, Maduro, SG, Pereira, BV, et al. Chronic heart disease after treatment of oral acute Chagas disease. Arq Bras Cardiol 2016;107:184–6.Google Scholar
Aras, R, da Matta, JA, Mota, G, et al. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003;81:414–16.Google Scholar
Aufderheide, AC, Salo, W, Madden, M, et al. A 9,000 year record of Chagas’ disease. Proc Natl Acad Sci USA 2004;101:2034–9.Google Scholar
Basquiera, AL, Sembaj, A, Aguerri, AM, et al. Risk progression to chronic Chagas cardiomyopathy: Influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003;89:1186–90.Google Scholar
Belisario Falchetto, E, Costa, SC, Rochitte, CE. Diagnostic challenges of Chagas cardiomyopathy and CMR imaging. Glob Heart 2015;10:181–7.Google Scholar
Benaim, G, Paniz Mondolfi, AE. The emerging role of amiodarone and dronedarone in Chagas disease. Nat Rev Cardiol 2012;9:605–9.Google Scholar
Benedictus, MR, Leeuwis, AE, Binnewijzend, MA, et al. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease. Eur Radiol 2016; in press.Google Scholar
Benvenuti, LA, Roggério, A, Freitas, HF, et al. Chronic American trypanosomiasis: Parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 2008;102:481–7.CrossRefGoogle ScholarPubMed
Bern, C. Chagas disease in the immunosuppressed host. Cur Opin Infect Dis 2012;25:450–7.Google ScholarPubMed
Bern, C. Chagas’ disease. N Engl J Med 2015;373:456–66.CrossRefGoogle ScholarPubMed
Bern, C, Montgomery, SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:e52–4.CrossRefGoogle ScholarPubMed
Bern, C, Martin, DL, Gilman, RH. Acute and congenital Chagas disease. Adv Parasitol 2011;75:19–47.Google Scholar
Bestetti, RB, Freitas, OC, Muccillo, G, et al. Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas’ disease. Eur Heart J 1993;14:1610–14.Google Scholar
Bestetti, RB, Restini, CB, Couto, LB. Carlos Chagas discoveries as a drop back to scientific construction of chronic Chagas heart disease. Arq Bras Cardiol 2016;107:63–70.Google Scholar
Braga, J, Labrunie, A, Villaça, F, et al. Thromboembolism in chronic Chagas’ heart disease. São Paulo Med J 1995;113:862–6.CrossRefGoogle ScholarPubMed
Braga, JC, Reis, F, Aras, R, et al. Clinical and therapeutics aspects of heart failure due to Chagas disease. Arq Bras Cardiol 2006;86:297–302.Google Scholar
Braggion-Santos, MF, Volpe, GJ, Pazin-Filho, A, et al. Sudden cardiac death in Brazil: A community-based autopsy series (2006–2010). Arq Bras Cardiol 2015;104:120–7.Google Scholar
Cardoso, AV, Lescano, SA, Amato Neto, V, et al. Survival of Trypanosoma cruzi in sugar cane used to prepare juice. Rev Inst Med Trop Sao Paulo 2006;48:287–9.Google Scholar
Carod-Artal, FJ. Stroke: A neglected complication of American trypanosomiasis (Chagas’ disease). Trans R Soc Trop Med Hyg 2007;1–1:1075–80.Google Scholar
Carod-Artal, FJ. Policy implications of the changing epidemiology of Chagas disease and stroke. Stroke 2013;44:2356–60.Google Scholar
Carod-Artal, FJ, Vargas, AP, Melo, M, et al. American trypanosomiasis (Chagas’ disease): An unrecognized cause of stroke. J Neurol Neurosurg Psychiatry 2003;74:516–18.CrossRefGoogle Scholar
Carod-Artal, FJ, Vargas, AP, Horan, TA, et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005;36:965–70.Google Scholar
Chagas, C. Nova tripanozomiaze humana. Estudo sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.gen. n.sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1909; 1:159–218.Google Scholar
Cougo-Pinto, PT, dos Santos, BL, Dias, FA, et al. Safety of IV thrombolysis in acute ischemic stroke related to Chagas disease. Neurology 2013;81:1773–5.Google Scholar
Corral, RS, Guerrero, NA, Cuervo, H, et al. Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes. PLoS Negl Trop Dis 2013;7:e2034.CrossRefGoogle ScholarPubMed
da Matta, JA, Aras, R Jr, de Macedo, CR, et al. Stroke correlates in chagasic and non-chagasic cardiomyopathies. PLoS One 2012;7:e35116.Google Scholar
de Andrade, AL de, Zicker, F, de Oliveira, RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996;348:1407–13.Google Scholar
Dias, JC. The indeterminate form of human chronic Chagas’ disease. A clinical epidemiological review. Rev Soc Bras Med Trop 1989;22:147–56.Google Scholar
Dias, JC. Evolution of Chagas disease screening programs and control programs: Historical perspective. Glob Heart 2015;10:193–202.Google Scholar
Dias, JC, Silveira, AC, Schofield, CJ. The impact of Chagas disease control in Latin America: A review. Mem Inst Oswaldo Cruz 2002;97:603–12.Google Scholar
Dias, JO Jr, da Costa Rocha, MO, de Souza, AC, et al. Assessment of the source of ischemic cerebrovascular events in patients with Chagas disease. Int J Cardiol 2014;176:1352–4.Google Scholar
Forsyth, CJ, Hernandez, S, Olmedo, W et al. Safety profile of nifurtimox for treatment of Chagas disease in the United States. Clin Infect Dis 2016;63:1056–62.CrossRefGoogle ScholarPubMed
Gurgel, CB, Ferreira, MC, Mendes, CR, et al. Apical lesions in Chagas’ heart disease patients: An autopsy study. Rev Soc Bras Med Trop 2010;43:709–12.Google Scholar
Jesus, PA, Neville, I, Cincura, C, et al. Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure. Cerebrovasc Dis 2011;31:19–23.CrossRefGoogle ScholarPubMed
Kalil Filho, R, de Albuquerque, CP. Magnetic resonance imaging in Chagas heart disease. São Paulo Med J 1995;113:880–3.Google Scholar
Kuehn, BM. Chagas heart disease an emerging concern in the United States. Circulation 2016;134:895–6.Google Scholar
Lee-Felker, SA, Thomas, M, Felker, ER, et al. Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy. Clin Radiol 2016;71:618.e1–7.Google Scholar
Lewis, MD, Kelly, JM. Putting infection dynamics at the heart of Chagas disease. Trends Parasitol 2016 epub ahead of print.Google Scholar
Lorga Filho, AM, Azmus, AD, Soeiro, AM, et al. Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology. Arq Bras Cardiol 2013;10 (Suppl 3): 1–95.Google Scholar
Mady, C, Cardoso, RHA, Barretto, AC et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 1994;90:3098–102.Google Scholar
Marcolino, MS, Palhares, DM, Ferreira, LR, et al. Electrocardiogram and Chagas disease: A large population database of primary care patients. Glob Heart 2015;10:167–72.Google Scholar
Martí-Carvajal, AJ, Kwong, JS. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy. Cochrane Database Syst Rev 2016;7:CD009077Google ScholarPubMed
Massaro, AR, Dutra, AP, Almeida, DR, et al. Transcranial Doppler assessment of cerebral blood flow: Effect of cardiac transplantation. Neurology 2006;66:124–6.Google Scholar
Miles, MA, Feliciangeli, MD, de Arias, AR. American trypanosomiasis (Chagas’ disease) and the role of molecular epidemiology in guiding control strategies. BMJ 2003;326:1444–8.Google Scholar
Montanaro, VV, da Silva, CM, de Viana Santos, CV, et al. Ischemic stroke classification and risk of enosis in patients with Chagas disease. J Neurol 2016; 263:2411–15.Google Scholar
Morel, CM. Chagas disease, from discovery to control – and beyond: History, myths and lessons to take home. Mem Inst Oswaldo Cruz 1999;94 Suppl 1:3–16.Google Scholar
Morillo, CA, Marin-Neto, JA, Avezum, A, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373(14):1295–306.CrossRefGoogle ScholarPubMed
Nunes, MC, Barbosa, MM, Ribeiro, AL, et al. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: A prospective follow-up study. J Neurol Sci 2009;278:96–101.Google Scholar
Nunes, MC, Dones, W, Morillo, CA, et al. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol 2013;62:767–76.CrossRefGoogle ScholarPubMed
Nunes, MC, Kreuser, LJ, Ribeiro, AL, et al. Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease. Glob Heart 2015;10:151–7.Google Scholar
Oliveira-Filho, J, Viana, LC, Vieira de Melo, RM et al. Chagas disease is an independent risk factor for stroke: Baseline characteristics of Chagas disease cohort. Stroke 2005;36:2015–17.CrossRefGoogle ScholarPubMed
Oliveira-Filho, J, Vieira-de-Melo, RM, Reis, PS, et al. Chagas disease is independently associated with brain atrophy. J Neurol 2009;256:1363–5.CrossRefGoogle ScholarPubMed
Paixão, LC, Ribeiro, AL, Valacio, RA, et al. Chagas disease: Independent risk factor for stroke. Stroke 2009;40:3691–4.Google Scholar
Pazin-Filho, A, Romano, MM, Almeida-Filho, OC, et al. Minor segmental wall motion abnormalities detected in patients with Chagas’ disease have adverse prognostic implications. Braz J Med Biol Res 2006;39:483–7.Google Scholar
Peix, A, Garcia, R, Sánchez, J, et al. Myocardial perfusion imaging and cardiac involvement in the inderminate phase of Chagas disease. Arq Bras Cardiol 2013;100:114–17.CrossRefGoogle Scholar
Pirard, M, Iihoshi, N, Boelaert, M, et al. The validity of serologic test for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005;45:554–61.Google Scholar
Pitella, JE. Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 1984;42:105–15.Google Scholar
Prata, A. Evolution of the clinical and epidemiological knowledge about Chagas disease 90 years after its discovery. Mem Inst Oswaldo Cruz 1999;94: Suppl 1:81–8.Google Scholar
Rassi, A Jr, Rassi, A, Little, WC, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 2006;355:799–808.Google Scholar
Rassi, A Jr, Rassi, A, Marin-Neto, JA. Chagas disease. Lancet 2010;375:1388–402.Google Scholar
Rassi, DC, Vieira, ML, Arruda, AL, et al. Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction. Arq Bras Cardiol 2014;102:245–52.Google Scholar
Regueiro, A, García-Álvarez, A, Sitges, M, et al. Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance. Int J Cardiol 2013;165:107–12.Google Scholar
Requena-Méndez, A, Aldasoro, E, de Lazzari, E, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: A systematic review and meta-analysis. PLoS Negl Trop Dis 2015. February 13;9:e0003540Google Scholar
Requena-Méndez, A, Moore, DA, Subirà, C, et al. Addressing the neglect: Chagas disease in London, UK. Lancet Glob Health 2016;4:e231–3.Google Scholar
Ribeiro, AL, Rocha, MO. Indeterminate form of Chagas disease: Considerations about diagnosis and prognosis. Rev Soc Bras Med Trop 1998;31:301–14.Google Scholar
Rochitte, CE, Oliveira, PF, Andrade, JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: A marker of disease severity. J Am Coll Cardiol 2005;46:1553–8.CrossRefGoogle ScholarPubMed
Rothhammer, F, Allison, MJ, Núñez, L, et al. Chagas’ disease in pre-Columbian South America. Am J Phys Anthropol 1985;68:495–8.Google Scholar
Samuel, J, Oliveira, M, Correa de Araújo, RR, et al. Cardiac thrombosis and thromboembolism in chronic Chagas’ heart disease. Am J Cardiol 1983;52:147–51.Google Scholar
Schmunis, GA, Yadon, ZE. Chagas disease: A Latin American health problem becoming a world health problem. Acta Trop 2010;115:14–21.Google Scholar
Sousa, AS, Xavier, SS, de Freitas, FR, et al. Prevention strategies of cardioembolic ischemic stroke in Chagas disease. Arq Bras Cardiol 2008;91:280–4.Google Scholar
Trabuco, CC, Pereira de Jesus, PA, Bacellar, AS, et al. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology 2005;64:170–1.Google Scholar
Torreão, JA, Ianni, BM, Mady, C, et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2015;17:97.CrossRefGoogle ScholarPubMed
Vilas Boas, LG, Bestetti, RB, Otaviano, AP, et al. Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy. Int J Cardiol 2013;167:486–90.Google Scholar
Viotti, RJ, Vigliano, C, Laucella, S, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 2004;90:655–60.Google Scholar
Walsh, JF, Molyneux, DH, Birley, MH. Deforestation: Effects on vector-borne disease. Parasitology 1993;106 (Suppl): S55–75.Google Scholar
World Health Organization (WHO). Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015;90:33–43.Google Scholar
Yadon, ZE, Schmunis, GA. Congenital Chagas disease: Estimating the potential risk in the United States. Am J Trop Med Hyg 2009;81:927–33.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×